160 related articles for article (PubMed ID: 34985386)
1. LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1.
Liu H; Liu L; Liu Q; He F; Zhu H
Cell Cycle; 2022 Feb; 21(4):416-426. PubMed ID: 34985386
[TBL] [Abstract][Full Text] [Related]
2. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
[TBL] [Abstract][Full Text] [Related]
4. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S; Li K
BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
[TBL] [Abstract][Full Text] [Related]
5.
Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
Hu YC; Wang AM; Lu JK; Cen R; Liu LL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5049-5055. PubMed ID: 29228418
[TBL] [Abstract][Full Text] [Related]
7. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
[No Abstract] [Full Text] [Related]
8. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract][Full Text] [Related]
9. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
[TBL] [Abstract][Full Text] [Related]
10. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
Zhou H; Ma Y; Zhong D; Yang L
Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
[TBL] [Abstract][Full Text] [Related]
14. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
Duan H; Li X; Chen Y; Wang Y; Li Z
Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
Fu J; Zhang Y; Wang M; Hu J; Fang Y
J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOXD-AS1 promotes the progression of pancreatic cancer through miR-664b-3p/PLAC8 axis.
Chen L; Niu W; Zhu D; Shao W; Qian Y
Pathol Res Pract; 2022 Apr; 232():153836. PubMed ID: 35279480
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
18. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
[TBL] [Abstract][Full Text] [Related]
20. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]